Understanding molecular changes in progression of head and neck squamous cell carcinoma (HNSCC) is essential for predicting clinical outcome and for developing effective therapies for treating the disease. Plakophilin-1 is a member of the Armadillo (Arm) protein family that is a structural component of the cell-cell adhesion junction known as the desmosome. In addition, plakophilin-1 is found in the nucleus, where its function is unknown. A well-studied member of the Arm family, ?-catenin, normally associates at the plasma membrane with the adherens cell-cell adhesion complex but also is found in the nucleus where it is a transcriptional regulator in the Wnt signaling pathway and plays a critical role in colon cancer. Data presented in this proposal show that not only is plakophilin-1 protein expression reduced in HNSCC, reducing plakophilin-1 expression in cell lines leads to increased cell motility in vitro. The central hypothesis for this project is that plakophilin-1, similar to ?-catenin, plays roles in both cell-cell adhesion and gene expression and that a shift in these cellular events plays a critical role in the malignant progression of HNSCC. The goal for the proposed work is to define the nuclear role for plakophilin-1 in HNSCC by showing that loss of plakophilin-1 expression alters the expression of genes relevant to tumor progression.
The specific aims are (1) to determine the mechanisms of plakophilin-1 translocation to the nucleus, (2) to determine the nuclear function of the plakophilin-1/TLS complex, and (3) to determine the role of plakophilin-1 target genes in HNSCC progression. This work will be greatly aided by two tools already developed for the project: a highly specific monoclonal antibody to plakophilin-1 and an activatable form of plakophilin-1 that can be exogenously expressed in cells. Defining the nuclear function of plakophilin-1 will lay the ground work for identifying new prognostic markers for HNSCC and also potential targets for novel therapeutic strategies for treating the disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
5R01DE016905-04
Application #
7616518
Study Section
Tumor Microenvironment Study Section (TME)
Program Officer
Shirazi, Yasaman
Project Start
2006-07-01
Project End
2011-05-31
Budget Start
2009-06-01
Budget End
2011-05-31
Support Year
4
Fiscal Year
2009
Total Cost
$352,918
Indirect Cost
Name
University of Nebraska Medical Center
Department
Dentistry
Type
Schools of Dentistry
DUNS #
168559177
City
Omaha
State
NE
Country
United States
Zip Code
68198
Katafiasz, Dawn; Smith, Lynette M; Wahl 3rd, James K (2011) Slug (SNAI2) expression in oral SCC cells results in altered cell-cell adhesion and increased motility. Cell Adh Migr 5:315-22
Roberts, Brett J; Pashaj, Anjeza; Johnson, Keith R et al. (2011) Desmosome dynamics in migrating epithelial cells requires the actin cytoskeleton. Exp Cell Res 317:2814-22
Wang, Ling; Fisher, Laura A; Wahl 3rd, James K et al. (2011) Monoclonal antibodies against Xenopus greatwall kinase. Hybridoma (Larchmt) 30:469-74
Sobolik-Delmaire, Tammy; Reddy, Roopa; Pashaj, Anjeza et al. (2010) Plakophilin-1 localizes to the nucleus and interacts with single-stranded DNA. J Invest Dermatol 130:2638-46
Mahoney, My G; Sadowski, Sara; Brennan, Donna et al. (2010) Compound heterozygous desmoplakin mutations result in a phenotype with a combination of myocardial, skin, hair, and enamel abnormalities. J Invest Dermatol 130:968-78
Bass-Zubek, Amanda E; Hobbs, Ryan P; Amargo, Evangeline V et al. (2008) Plakophilin 2: a critical scaffold for PKC alpha that regulates intercellular junction assembly. J Cell Biol 181:605-13
Keim, Sarah A; Johnson, Keith R; Wheelock, Margaret J et al. (2008) Generation and characterization of monoclonal antibodies against the proregion of human desmoglein-2. Hybridoma (Larchmt) 27:249-58